Language:
Finally, the Regulation for Research and Medicinal Use of Cannabis and its Pharmacological Derivatives is enacted
January 13, 2021
After a long wait, on January 12, 2020, the General Health Law Regulation on Sanitary Control for the Production, Research and Medicinal Use of Cannabis and its Pharmacological Derivatives was published in the Federal Official Gazette.
The new Cannabis Regulation is intended to regulate, promote, and monitor the use of cannabis and its derivatives for medicinal use. The regulation includes provisions regarding primary production, research, manufacturing of pharmacological derivatives and medicines, distribution, advertising, prescription, and commercialization.
This regulation will come into force on January 13, 2020.
OLIVARES is analysing in detail the effects of this regulation, to inform and advise our clients.
Newsletters - Life Science
- Impact of the “Comprehensive and Progressive Agreement for Trans-Pacific Partnership” on Life Sciences in Mexico March 16, 2018
- Mexico. Amendments to the equivalence Decree to import health supplies without marketing authorization. June 30, 2021
- The Supreme Court of Justice authorized the recreational use of cannabis July 6, 2021
- Nuevo Mecanismo para Compra de Medicamentos e Insumos Médicos en México. November 14, 2024
- OLIVARES & CIA LITIGATION STRATEGY ENDS WITH MEXICAN SUPREME COURT DECISION SECURING PROTECTION FOR PHARMA PRODUCT PATENTS AND ESTABLISHING PRECEDENT FOR LINKAGE REGULATIONS January 13, 2010
- Mexico’s New Government Announces Plan to Overhaul the Health System December 17, 2018
- Labeling of medicines exclusively intended for public sector in Mexico December 4, 2020
- Data Package Exclusivity (DPE). Mexico intends to pass a new law to fully recognize DPE rights in the domestic law. March 11, 2011